Pedestrian injured in collision with railway train or railway vehicle

VWXY20_PEDES_INJURED_COLLIS_W_RAILW_TRAIN_RAILW_VEHIC

No definition available.

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	520210
1. Apply sex-specific rule None	520210
2. Check conditions None	520210
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — V05 Cause of death: ICD-10 — V05 2 out of 7 registries used, show all original rules.	38
4. Check minimum number of events None	38
5. Include endpoints None	38
6. Filter based on genotype QC (FinnGen only)	38

Control definitions (FinnGen only)

Controls for this endpoint are individuals that are not cases.

Extra metadata

Level in the ICD hierarchy: 5
First used in FinnGen datafreeze: DF4
Parent code in ICD-10: V0

NAME	VWXY20_PEDES_INJURED_COLLIS_W_RAILW_TRAIN_RAILW_VEHIC
CONTROL_EXCLUDE
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	V05
HD_ICD_9
HD_ICD_8
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	V05
COD_ICD_9
COD_ICD_8
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Pedestrian injured in collision with railway train or railway vehicle based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	38	15	23
Unadjusted period prevalence (%)	0.01	0.01	0.01
Median age at first event (years)	47.32	43.45	49.85

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

No data available

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3033658) Prothrombin time (PT) actual/Normal

4.80

5.26

4.6

4.2

92.17

93.30

0.07

(3023368) Bacteria identified in Blood by Culture

4.00

4.08

3.4

4.8

—

(40758558) Short blood count panel - Blood

3.71

3.68

3.5

7.3

—

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

11.22

3.06

2.4

4.2

265.00

135.34

ug/l

—

(3021589) Normoblasts [#/volume] in Blood

118

3.05

2.81

4.9

7.0

0.00

e9/l

0.00

(36304419) Bacteria [Presence] in Urine

3.05

2.52

3.6

2.1

—

(3000991) Gas panel - Venous blood

4.27

2.27

7.9

13.0

—

(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count

2.64

2.09

3.4

2.4

—

(1761868) Lipid panel - Serum or Plasma

129

0.30

2.01

2.0

2.4

—

(3002256) Pathology report gross observation

3.05

1.96

1.3

1.1

—

(3021447) Carbon dioxide [Partial pressure] in Venous blood

3.49

1.90

4.9

2.2

6.13

5.58

kpa

—

(3007853) Bacteria identified in Skin by Aerobe culture

3.10

1.85

2.4

1.7

—

(3012544) pH of Venous blood

3.34

1.82

4.9

3.3

—

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

4.25

1.77

2.6

4.3

23.00

25.24

mmol/l

—

(3024354) Oxygen [Partial pressure] in Venous blood

3.36

1.65

2.2

1.9

6.17

4.87

kpa

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

0.00

1.65

0.0

4.5

—

31.66

—

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

116

2.05

1.28

7.1

10.0

1.20

1.22

mmol/l

1.47

107

(3031040) Bacteria [#/volume] in Urine by Automated count

156

1.97

1.17

3.7

3.6

—

141.20

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

2.30

1.15

2.2

1.5

—

(3000850) Epithelial cells [#/volume] in Urine

2.14

1.10

2.1

2.2

1.63

3.84

e6/l

—

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

111

0.46

1.05

5.0

2.2

87.00

72.14

nmol/l

—

105

(3042936) Bacteria identified in Isolate by Culture

2.15

1.03

2.4

3.1

—

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

211

1.97

1.02

6.5

7.8

89.52

74.51

u/l

0.97

199

(3022217) INR in Platelet poor plasma by Coagulation assay

2.26

0.94

26.2

16.6

—

1.06

—

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

1.94

0.90

3.1

2.7

—

(3019832) Treponema pallidum Ab [Presence] in Serum

2.11

0.89

2.8

1.4

—

(3026008) Bacteria identified in Urine by Culture

1.94

0.86

2.0

3.1

—

(3015736) pH of Urine

102

1.78

0.84

2.3

3.0

—

(3011397) Hemoglobin [Presence] in Urine by Test strip

1.95

0.84

2.0

3.4

—

(3001604) Monocytes [#/volume] in Blood

139

1.73

0.83

4.5

5.6

0.67

0.57

e9/l

0.73

124

(3044640) Blood type and Crossmatch panel - Blood

1.80

0.83

4.0

2.7

—

(3019225) pH of Specimen

0.00

0.82

0.0

4.9

—

(3006315) Basophils [#/volume] in Blood

140

1.71

0.81

4.5

5.6

0.05

0.04

e9/l

0.29

125

(3013115) Eosinophils [#/volume] in Blood

142

1.68

0.75

4.6

6.4

0.24

0.19

e9/l

0.44

130

(46235355) HIV 1 and 2 tests - Meaningful Use set

1.80

0.75

2.5

1.8

—

(1002224) Polysomnography panel

0.00

0.62

0.0

1.2

—

(3013826) Glucose [Moles/volume] in Serum or Plasma

167

1.58

0.61

3.9

8.0

6.53

6.62

mmol/l

0.07

159

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

120

1.58

0.59

4.9

5.1

—

(3026782) Osmolality of Urine

1.64

0.52

2.4

2.1

422.29

603.36

mosm/kgh2o

—

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

1.70

0.45

1.4

1.5

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

1.70

0.45

1.4

1.5

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

215

1.48

0.45

3.2

3.4

—

(3022313) Gas panel - Capillary blood

0.00

0.42

0.0

1.2

—

(3027273) Bicarbonate [Moles/volume] in Venous blood

0.00

0.42

0.0

2.5

—

24.22

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

0.00

0.42

0.0

1.9

—

(3025941) Bacteria identified in Stool by Culture

0.00

0.41

0.0

1.1

—

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

305

1.62

0.41

17.9

12.5

32.91

20.32

mg/l

1.02

233

(42870588) Differential panel, method unspecified - Blood

1.47

0.40

3.8

6.0

—

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

1.55

0.38

1.3

1.8

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

1.36

0.35

2.7

1.6

—

(40768804) Tissue Pathology biopsy report

122

1.38

0.34

2.5

1.8

—

(3041096) Erythrocytes [Presence] in Urine by Automated

0.70

0.27

3.7

2.6

—

(3037467) Urinalysis macro (dipstick) panel - Urine

185

1.30

0.26

3.6

3.3

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

108

1.31

0.24

6.0

4.7

1.72

1.82

ug/l

0.05

(40768797) Stomach Pathology biopsy report

1.29

0.23

1.0

1.3

—

(3018405) Lactate [Moles/volume] in Arterial blood

0.00

0.22

0.0

2.1

—

1.55

—

(40768793) Breast Pathology biopsy report

0.00

0.22

0.0

1.3

—

(3039443) Prostate specific Ag panel - Serum or Plasma

0.00

0.22

0.0

1.2

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

0.00

0.22

0.0

1.3

—

(4034850)

0.00

0.21

0.0

7.2

—

(3019150) Specific gravity of Urine by Refractometry

1.21

0.20

3.2

3.6

—

1.02

—

(3044889) 12 lead EKG panel

190

1.24

0.18

3.5

3.0

—

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

0.73

0.17

2.3

1.9

1.37

1.21

mmol/l

—

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

0.77

0.16

1.0

2.7

42.14

54.01

u/l

—

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

1.22

0.13

3.1

1.7

102.40

99.51

pmol/l

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

1.16

0.09

1.5

—

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

324

0.92

0.09

9.5

9.6

26.28

27.57

u/l

0.22

315

(3003694) ABO and Rh group [Type] in Blood

1.12

0.08

1.4

—

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

269

0.89

0.04

4.5

3.9

2.53

1.83

mu/l

0.63

246

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

106

0.92

0.01

3.3

3.1

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

0.00

0.0

1.5

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

0.00

0.0

1.5

—

(3003434) Protein [Mass/volume] in Pleural fluid

0.00

0.0

1.7

—

36.47

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

0.00

0.0

1.5

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

0.00

0.0

1.5

—

(3050129) First trimester maternal screen panel - Serum or Plasma

0.00

0.0

1.3

—

(3023511) Choriogonadotropin [Units/volume] in Urine

0.00

0.0

2.0

—

(4094501)

0.00

0.0

1.3

—

(3036782) Glucose [Moles/volume] in Pleural fluid

0.00

0.0

1.3

—

6.28

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

0.00

0.0

1.2

—

(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction

0.00

0.0

1.3

—

209.43

—

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

0.00

0.0

1.2

—

0.31

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

0.00

0.0

1.7

—

(3023410) Appearance of Cerebral spinal fluid

0.00

0.0

1.3

—

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

0.00

0.0

1.2

—

1.32

—

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

0.00

0.0

2.2

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

0.00

0.0

1.0

—

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

0.00

0.0

1.4

—

(40768806) Pleura Pathology biopsy report

0.00

0.0

3.0

—

(3034770) Mitochondria Ab [Titer] in Serum

0.00

0.0

1.5

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

0.93

0.00

3.6

1.9

—

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

0.00

0.0

1.3

—

0.95

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

0.00

0.0

1.4

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

0.00

0.0

2.3

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

0.00

0.0

2.0

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

0.00

0.0

1.4

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

0.00

0.0

1.2

—

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

0.00

0.0

1.4

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

0.00

0.0

1.9

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

0.00

0.0

1.2

—

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

0.00

0.0

1.9

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

0.00

0.0

1.7

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

0.00

0.0

1.2

—

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

0.00

0.0

2.8

—

1.02

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

0.00

0.0

1.0

—

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

1.05

0.00

3.6

1.9

—

(3001122) Ferritin [Mass/volume] in Serum or Plasma

110

1.00

0.00

4.5

2.7

167.91

109.19

ug/l

0.43

105

(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma

0.00

0.0

1.3

—

56.43

—

(42529406) Shigella sp [Presence] in Stool by Culture

0.00

0.0

1.2

—

(40768795) Lymph node Pathology biopsy report

0.00

0.0

1.2

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

0.00

0.0

2.4

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

0.00

0.0

2.0

—

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

0.00

0.0

2.0

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

0.00

0.0

1.3

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

0.00

0.0

1.0

—

(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

0.00

0.0

1.2

—

(3037756) Immunofixation for Serum or Plasma

0.00

0.0

3.6

—

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

0.00

0.0

1.2

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

0.00

0.0

1.2

—

(3041354) Potassium [Moles/volume] in Venous blood

0.00

0.0

2.3

—

4.06

—

(3035285) Chloride [Moles/volume] in Venous blood

0.00

0.0

2.3

—

107.75

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

0.00

0.0

2.7

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

0.00

0.0

1.3

—

(3008037) Lactate [Moles/volume] in Venous blood

0.00

0.0

2.1

—

1.27

—

(3038515) Glucose [Moles/volume] in Venous blood

0.00

0.0

2.1

—

6.92

—

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

0.00

0.0

1.2

—

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

0.00

0.0

2.4

—

0.36

—

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

0.00

0.0

1.2

—

(1761482) Bacteria [#/volume] in Urine by Culture

0.00

0.0

3.3

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

0.00

0.0

1.9

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

0.00

0.0

1.7

—

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

0.00

0.0

1.1

—

Mortality – FinRegistry

↥

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

Relationships between endpoints

↥

Index endpoint: VWXY20_PEDES_INJURED_COLLIS_W_RAILW_TRAIN_RAILW_VEHIC – Pedestrian injured in collision with railway train or railway vehicle

GWS hits: -

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

≡ Risteys

FG R12 + FR

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Pedestrian injured in collision with railway train or railway vehicle

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

All original rules

Similar endpoints

Case counts by codes

Upset plot

Case counts by code for Pedestrian injured in collision with railway train or railway vehicle (VWXY20_PEDES_INJURED_COLLIS_W_RAILW_TRAIN_RAILW_VEHIC)

Summary Statistics

-FinRegistry-

-FinnGen-

Key figures

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

LabWAS

Mortality – FinRegistry

Relationships between endpoints